-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Calidi Biotherapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2021 to Q3 2025.
- Calidi Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$5.15M, a 1.88% decline year-over-year.
- Calidi Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$20M, a 23.8% increase year-over-year.
- Calidi Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$22.1M, a 24.2% increase from 2023.
- Calidi Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$29.2M, a 14.9% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)